Painkiller demand drives crop expansion beyond Tasmania
GEOFF HISCOCK, Contributing writer
SYDNEY — Strong global demand for painkillers is underpinning moves in Australia, the world’s biggest legal grower of opium alkaloids, to expand the cultivation of opium poppies.
Consumers around the world spend about $30 billion a year on pain medication, with North America and Europe the biggest markets for codeine, thebaine, morphine and other opiates that go into branded pharmaceutical products such as Panadeine, OxyContin and Roxanol.
From just 10% of the total production area, Australia produces about half of the concentrate of poppy straw (CPS) used by the global pharmaceutical industry, ahead of Turkey (23%), France (21%) and Spain (4%).
Crossing the water (more…)